Avoiding Independent Director Challenges In Ch. 11 Litigation
Recently, a materially revised Chapter 11 restructuring plan of reorganization was negotiated, in part, by a purportedly independent special committee of the board of Purdue Pharma LP.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article